Altaire Pharmaceuticals, Inc.
Medical device contract manufacturer · Aquebogue, New York, United States
Altaire Pharmaceuticals, Inc. is a medical device contract manufacturer with a registered site in Aquebogue, New York, United States. The US FDA lists 1 medical device site and 1 drug manufacturing or testing site registered to the company, with devices in ophthalmic.
Altaire Pharmaceuticals at a glance
What does Altaire Pharmaceuticals do?
Medical specialties of its FDA-listed devices
Device types listed with the FDA
Operations at its FDA-registered drug sites
Where is Altaire Pharmaceuticals located?
Registered site: Aquebogue, New York, United States
- Aquebogue, New YorkAltaire Pharmaceuticals, Inc. · FDA device site
- Aquebogue, New YorkAltaire Pharmaceuticals Inc. · FDA drug site
Frequently asked questions about Altaire Pharmaceuticals
Where is Altaire Pharmaceuticals based?
Altaire Pharmaceuticals, Inc. is based in Aquebogue, New York, United States.
What does Altaire Pharmaceuticals do?
Altaire Pharmaceuticals, Inc. is a medical device contract manufacturer. Its FDA-listed medical devices fall under ophthalmic. Its FDA-registered drug sites are registered for API manufacturing and manufacturing.
How many FDA-registered sites does Altaire Pharmaceuticals have?
The US FDA lists 2 registered sites for Altaire Pharmaceuticals, Inc..
Similar companies
- Click Therapeutics, Inc.New York City, New York, United States
- Baxter Healthcare CorporationRound Lake, Illinois, United States
- Minnetronix Medical, Inc.Saint Paul, Minnesota, United States
- Intelligent Hearing Systems CorpMiami, Florida, United States
- Medline Industries, LPNorth Mankato, Minnesota, United States
- Integra Lifesciences CorporationPlainsboro, New Jersey, United States
- C. R. Bard, Inc.Covington, Georgia, United States
- Smith & Nephew, Inc.Memphis, Tennessee, United States
Work with CROs and CDMOs like Altaire Pharmaceuticals
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences